Search Within

Christopher Riedl

  1. "2015"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
Groups
  1. Molecular Imaging and Therapy Service (8)
  2. Radiology, Department of (8)
  3. Sloan Kettering Institute Postdocs (5)
  4. Biostatistics Service (1)
  5. Body Imaging Service (1)
  6. Breast Imaging Service (1)

More Groups

People
  1. Gary Ulaner (6)
  2. Katja Pinker-Domenig (5)
  3. Leonard Ong (5)
  4. Maxine Jochelson (5)
  5. Wolfgang Weber (5)
  6. Maura Dickler (4)

More People

Years
  1. 2015 (8)
Publications
  1. Journal of Nuclear Medicine (5)
  2. Journal of Clinical Oncology (3)
Publishers
  1. Society of Nuclear Medicine (5)
  2. American Society of Clinical Oncology (3)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of 18F-FDG PET/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive ductal carcinoma
    Journal Article

    Hogan, M. P.; Goldman, D. A.; Dashevsky, B.; Riedl, C. C.; Gönen, M.; Osborne, J. R.; Jochelson, M.; Hudis, C.; Morrow, M.; Ulaner, G. A.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Comparison of FDG-PET/CT with contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients: A retrospective analysis
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M.; Ulaner, G.; Mcarthur, H.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • How does the number of lesions analyzed impact response assessment with PERCIST in breast cancer?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M.; Ulaner, G.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Comparison of SUVmax and SUVpeak for response assessment in stage 4 non-small cell lung cancer (NSCLC) by FDG PET/CT
    Meeting Abstract

    Ong, L.; Rager, O.; Lohrmann, C.; Riedl, C.; Pinker, K.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • FDG-PET/CT versus contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Mcarthur, H. L.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is response classification with PERCIST in stage IV breast cancer influenced by the number of lesions assessed?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Reply: Breast cancer staging: To which women should 18F-FDG PET/CT be offered?
    Journal Article

    Ulaner, G. A.; Riedl, C. C.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density
    Journal Article

    Riedl, C. C.; Luft, N.; Bernhart, C.; Weber, M.; Bernathova, M.; Tea, M. K. M.; Rudas, M.; Singer, C. F.; Helbich, T. H.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save